eWave Patch for Heart Monitoring

AB
CD
Overseen ByChris Daniel
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wearlinq
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.

Who Is on the Research Team?

CD

Chris Daniel

Principal Investigator

WearLinq, Inc.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am over 18 and can give my consent.
Capable of using a smartphone app
I am willing to shave the area where the patch will be applied if necessary.

Exclusion Criteria

Planning to undergo an MRI during the study period
Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological condition that could confound placement or results
I do not have open wounds or infections on my chest where a device might be placed.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive and apply the WearLinq patch for 7 consecutive days

1 week

Extended Use

A subset of participants will continue to use the WearLinq patch for 30 consecutive days

4 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • eWave Patch

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Extended Use CohortExperimental Treatment1 Intervention
Group II: 7 Day StudyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wearlinq

Lead Sponsor

ABio Clinical Research Partners

Collaborator